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Abstract  
Aim: To achieve high and sustained magnetic particle (MP)-loading in a proliferative and 
endocytotically-active neural transplant population (astrocytes) through tailored magnetite content 
in polymeric iron oxide particles. Materials & methods: MPs of varying magnetite content were 
applied to primary-derived rat cortical astrocytes ± static/oscillating magnetic fields to assess 
labeling efficiency and safety. Results: Higher magnetite content particles display high but safe 
accumulation in astrocytes, with longer-term label retention versus lower/no magnetite content 
particles. Magnetic fields enhanced loading extent. Dynamic live cell imaging of dividing labeled 
astrocytes demonstrated that particle distribution into daughter cells is predominantly ‘asymmetric’. 
Conclusion: These findings could inform protocols to achieve efficient MP loading into neural 
transplant cells, with significant implications for post-transplantation tracking/localization. 
Key words: Astrocytes, magnetite, magnetolabeling, cell transplantation, polymeric particles, label 
dilution 
 
Introduction 
Deploying magnetic particles (MPs) with cell therapies for magnetic cell localization and imaging 
applications is paving the way for safe and efficient delivery of cell transplant populations to sites of 
pathology, and allowing for non-invasive monitoring of grafts [1–4]. A major emergent area for such 
applications, given the limited regenerative capacity of the central nervous system, is in neural cell 
transplantation for the repair of neurological injury and disease. Labeling cells prior to transplantation 
requires a cell-particle combination that results in rapid and safe particle uptake by the majority of 
(ideally all) cells. However, the regenerative capacity of most transplant populations relies partially 
on their proliferative capacity which results in rapid dilution of intracellular particle accumulations in 
labeled cells [5]. Particle loss can also occur via exocytosis, potentially compromising magnetic cell 
localization and imaging success [6]. Therefore, a further requirement for transplant cell labeling is 
long term retention of sufficient particles per cell to confer utility, despite the proliferative nature of 
the cell, which could be achieved by high initial loading of label into graft cells. 
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In order to achieve this goal, we require a clear understanding of both the physicochemical and 
biological parameters that govern particle loading in transplant populations. However, there is a 
major knowledge gap regarding the factors that contribute to successful ‘magnetolabeling’ and label 
retention in neural cells. These issues are complicated by the complexity of the architecture of the 
nervous system wherein multiple cell types are present possessing distinct biological properties. 
These cell types vary greatly in terms of proliferative and endocytotic capacity, cell-specific modes 
of intracellular particle processing and susceptibility to particle induced toxicity, requiring detailed 
characterizations on a cell-by-cell basis for neurological applications [7].  
We recently proved that systematic tailored increases in the magnetite content of polymeric particles 
could significantly enhance cell labeling (>95% cells labeled) in the typically ‘hard-to-label’ transplant 
population of neural stem cells (NSCs [8]). However, this study did not evaluate the longer term 
retention of particles of different magnetite content by the labeled cells, or establish the pattern of 
‘inheritance’ of particles by daughter NSCs post-proliferation. Furthermore, it is well established that 
uptake of nanoparticles is mediated via a range of endocytotic mechanisms [9–12]. In this context, 
it should be noted that NSCs have relatively small cell bodies, elaborate limited amounts of cell 
membrane and appear in ultrastructural observations to possess comparatively quiescent 
membranes [13]. How neural transplant cell populations with greater levels of endocytotic activity 
handle such high magnetite content MPs is unclear, but it can be postulated that such cell/MP 
combinations can result in greater enhancement of cell labeling for neural transplant applications.  
In order to address these issues, we have applied particles with differing magnetite content to 
cortical astrocytes of primary origin. The astrocytes offer major promise as a transplant population 
[14–16] and also play key roles in lesion sites post-injury [17]; as such these are of great interest as 
a target cell population for nanotechnology studies. Astrocytes have major homeostatic functions in 
the CNS, for example in the maintenance of normal ionic concentrations and neurotransmitter levels 
in the extracellular space [18,19]. Consistent with these roles, astrocytes display high levels of 
membrane activity and can mediate nanoparticle uptake via a broad range of endocytotic 
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mechanisms [19,20]. Indeed, in a recent ultrastructural study using an advanced and high resolution 
scanning electron microscopy technique, we showed that astrocytes are the dominant 
neuroepithelial population in terms of particle uptake, displaying extensive membrane ruffling with 
numerous filopodia/membrane pits in line with greater particle uptake/transfection, relative to other 
major neural cell types such as neurons and oligodendrocytes [21]; MPs appear to be relatively 
stable (not degraded) within these cells [7]. Of relevance to the current study, these cells also have 
a relatively short cell cycle time (ca. 20 h) making these ideal for capture of cell division events and 
dynamic imaging studies of particle inheritance [22,23]. Polymeric particles with different levels of 
magnetite content deployed in this study were formulated using biocompatible and biodegradable 
components highlighting their translational potential and justifying their use in this study [8]. The 
main study goals were to investigate the influence of tailored particle magnetite content on (i) 
astrocyte loading and (ii) particle retention, whilst evaluating the safety of the methods, and (iii) to 
investigate the profiles of particle inheritance in the daughter cells of labeled astrocytes using 
dynamic time lapse imaging. 
Materials & Methods 
The care and use of animals was in accordance with the Animals (Scientific Procedures) Act of 1986 
(UK), and approved by the local ethics committee. 
Astrocyte cell culture 
Disaggregated cerebral cortices from Sprague-Dawley rats (postnatal day 1-3) were used to 
establish mixed glial cultures. Following seven days’ culture in D10 medium (Dulbecco’s modified 
Eagle’s medium, 2 mM glutaMAX-I, 1 mM sodium pyruvate, 50 U/mL penicillin, 50 µg/mL 
streptomycin, and 10% fetal bovine serum), sequential overnight shakes facilitated astrocyte 
purification [24]. Astrocytes were enzymatically-detached (TrypLE synthetic trypsin, Life 
Technologies), plated on poly-D-lysine (PDL) coated T75 flasks, and maintained in D10 medium, as 
previously described [25]. Subconfluent cultures were enzymatically-detached by addition of TrypLE 
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and orbital shaking at 100 rpm, <5 min. Following centrifugation (1000 rpm; 4 min) and phosphate 
buffered saline (PBS) wash (800 µL), cells were re-suspended in D10 for plating.  
Magnetic particle characterization 
Superparamagnetic, PLA/PVA coated particles, with a fluorescent BODIPY® 564/570–PLA coating 
and of differing relative magnetite matrix loading, termed MP-0x (non-magnetite), MP-1x and MP-
5x, were prepared by the Boris Polyak Laboratory, Drexel University, Philadelphia, using published 
procedures [26]. These were formulated using biocompatible and biodegradable components 
[poly(lactic acid; PLA), poly(vinyl alcohol; PVA), magnetite and oleic acid]. Extensive 
characterization of these MPs has previously been undertaken [8,27]. In brief, the average sizes are 
similar for each particle type (hydrodynamic diameter 262-278 nm) with a slightly negative surface 
charge (-9.5 to -14.4 mV) The differing magnetite content of these particles alters magnetic 
responsiveness and weight ratio of the MPs, but not particle size or surface charge. FTIR 
spectroscopy confirmed similar organic composition of each particle type, with no alteration due to 
increased magnetite loading [8] (Table 1).   
Magnetic particle labeling utilizing the magnefect-nano device 
The MPs were evaluated for cellular labeling efficiency and extent of cellular accumulation over 
time. For particle uptake experiments, astrocytes were seeded onto PDL-coated glass coverslips in 
24-well plates (0.4 x 105 cells/cm2), and allowed to adhere for 24 h prior to addition of MPs, followed 
immediately by exposure to a magnetic field. Lyophilized MPs were re-suspended in sterile water 
and added to D10 at a concentration of 13 µg (MP-0x), 15 µg (MP-1x) and 26.5 µg (MP-5x) per mL 
of fresh D10 medium; each corresponding to an identical concentration (particles per mL), as MP 
density increases with greater magnetite content [8].  
Particles were added to cultures (0.3 mL per culture well), with control cultures receiving D10 without 
MPs. To enhance particle/cell interactions, a magnefect-nano device was used [high gradient 
neodymium iron boron (NdFeB) magnets with lateral oscillation capability and programmable 
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frequency/amplitude; field strength at magnet face 421 ± 20 mT (24-magnet array) and 303 ± 5 mT 
(96-magnet array); nanoTherics Ltd., Stoke-on-Trent, UK]. The superparamagnetic nature of the 
particles allows for magnetic responsiveness only when particles are exposed to a magnetic field 
and field gradient. Therefore, deploying a magnetic field and field gradient (permanent NdFeB 
magnets in this study) beneath the culture plate attracts the particles down to the cell monolayer, 
while the application of an oscillating field/gradient (termed later as a magnetic field condition for 
simplicity) theoretically causes particles to move horizontally along the magnet’s surface enhancing 
the likelihood of contact with cells, and/or oscillate in situ when attached to cell membrane, thus 
stimulating endocytotic mechanisms and enhancing cellular MP uptake [20,28–30]. Culture plates 
were exposed to a static magnetic field (frequency, F = 0 Hz), an oscillating field (F = 1 Hz; 200 µm 
amplitude) or no magnetic field (NF) for the first 30 minutes of the MP incubation period (either 4 or 
24 h; 37°C, 5% CO2/95% humidified air throughout). Then cells were washed twice with PBS to 
remove any particles not internalized by cells, and fixed with 4% paraformaldehyde (25 min at room 
temperature, RT).  
Long term particle retention 
Particle retention, i.e. percentage of cells labeled and the extent of MP accumulation were monitored 
over a 21 day period, together with assessment of particle safety. For these experiments, astrocytes 
were incubated with particles for 24 h, with exposure to magnetic field conditions for the first 30 
minutes, as detailed above, followed by PBS washes (x2) to remove non-internalized particles, then 
fresh D10 medium was added. To facilitate continued proliferation of astrocytes over the long term, 
coverslips containing MP-loaded cells were transferred to PDL-coated 6-well plates at 96 h, cultured 
up to day 7 with the coverslip containing cells then transferred to a fresh well at 14 days and 
cultivated up to 21 days. Cells were maintained in D10 medium with 50% refresh every 2-3 days, 
with some cultures fixed (PBS wash x2; 4% paraformaldehyde, 25 min, RT) at day 1 and every 4 
days thereafter up to day 21 (6 time points in total). 
Immunostaining 
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Cells were immunostained for glial fibrillary acidic protein (GFAP) to enable assessment of culture 
purity, morphological characteristics and intracellular localization of particles. Cells were incubated 
in blocker (5% normal donkey serum and 0.3% Triton X-100; 30 min at RT) followed by overnight 
incubation at 4°C in primary antibody, polyclonal rabbit anti-GFAP (Z0334; DakoCytomation, Ely, 
UK; 1:500 in blocker). Following two PBS washes (15 min/wash at RT), cells were incubated in 
blocker (30 min at RT) prior to incubation with secondary antibody (FITC-labeled donkey anti-rabbit, 
IgG; Jackson Laboratories, USA; 1:200 in blocker; 2-3 h at RT). Coverslips were washed with PBS 
(3 x 5 min) then mounted with the nuclear stain DAPI (4’,6-diamidino-2-phenylindole; Vector 
Laboratories, Peterborough, UK).  
Fluorescence imaging 
MP labeling efficiency, extent of particle accumulation and MP intracellular localization, together 
with culture characteristics and safety assessment, were assessed using fluorescence micrographs. 
These consisted of four images – fluorescent channels (BODIPY® 564/570-PLA MPs; FITC-GFAP+ 
astrocytes; DAPI stained nuclei) and phase image (Axio Scope A1 fluorescence microscope, 
AxioCam ICc1 digital camera and Axiovision software; Carl Zeiss MicroImaging, GmbH, Germany). 
A standardized exposure time was used for density quantification of BODIPY® 564/570-PLA MPs. 
For each of the experimental conditions, at least four micrographs, encompassing a minimum of 
100 nuclei, were quantified for statistical analyses. 
Particle inheritance- dynamic time lapse imaging 
Dynamic time-lapse imaging allowed determination of the pattern of particle inheritance in daughter 
cells of dividing astrocytes [Axio Zoom V16 with AxioCam ICm1 camera and ZEN software (Blue 
Ed., v.1.1.1.0); Carl Zeiss GmbH, Germany]. Time-lapse images were acquired from transmitted 
light and BODIPY® 564/570-relevant fluorescence channels for 48 h, post-addition of MPs. Visual 
observation of time-lapse imaging videos provided counts of symmetrical/non-symmetrical particle 
inheritance events. A total of 30 mitotic events were recorded (60 daughter cells) and each was 
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classified as ‘symmetric’ or ‘asymmetric’. The total area occupied by MPs was determined for both 
daughters, and events were classed as symmetrical inheritance when each daughter cell contained 
40-60% of this area, with non-symmetrical defined as >60% in one daughter cell.  
Histological analyses of culture properties 
Fluorescence micrographs were triple-merged (Photoshop CS5 Extended, Version 12 x32; Adobe, 
CA, USA) and viewed using ImageJ (NIH USA) to allow quantification of culture and particle uptake 
characteristics and safety assessments across each experimental condition. Culture purity was 
determined as the percentage of DAPI-stained nuclei which were GFAP+, with average cell counts 
determined from the number of nuclei per micrograph. To quantify astrocyte phenotype ratios, each 
astrocyte was classified based on morphological characteristics [Type 1 (flat, membranous, 
unbranched) or Type 2 (highly branched, complex cells)]. For each experimental condition, average 
cell count, distribution of astrocyte phenotype and percentage of pyknotic nuclei (defined as 
shrunken, fragmenting nuclei) were quantified from fluorescence micrographs.  
Integrated density-based technique for unbiased quantification of extent of cellular MP uptake 
In terms of quantification of cellular particle uptake, taking average measures of fluorescence (using 
plate readers) across cultures or assessing iron uptake by quantitative (culture wide) iron assays, 
assumes an even particle distribution between cells, and whilst arguably appropriate for cell lines 
(which behave in a relatively homogenous and clonal manner in respect of particle uptake), this 
approach is not suitable for evaluating MP uptake in the astrocyte cultures used in our studies which 
are derived from primary cortical tissue and show extensive heterogeneity in uptake. Moreover, 
fluorescence measurements typically include substantial extracellular (membrane-bound) particles 
(notably, up to 50% of the signal for astrocytes [31]). In this context, a flow cytometry approach was 
also considered but rejected as particles adherent to the plasma membrane lead to ‘false-positives’. 
Moreover, enzymatically-detached cells provide few morphological features for analysis, features 
pertinent to the assessment of uptake and toxicity in specific astrocyte classes. MP labeling 
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efficiency (% labeled cells) and the extent of particle accumulation within cells, were quantified using 
triple-merges of DAPI, GFAP and particle images/channels. The dense accumulation of internalized 
particles prevented exact particle counts per cell, therefore particle accumulation per cell was 
quantified using integrated density (ID - a measure of pixel intensity) values (ImageJ software, NIH 
USA). Merged fluorescence micrographs were scaled and, for each MP-labeled astrocyte, the total 
area per cell occupied by intracellular MPs was outlined, with this outline then being transferred to 
the un-merged particle channel from which a raw cellular ID measure was obtained. Five 
background measures were taken from the same un-merged particle channel. The cellular ID values 
are presented as a corrected total cell fluorescence (CTCF) measure, where: 
CTCF = ID – (area of selected cell X mean fluorescence of background readings) 
Therefore the resulting CTCF value represents the fluorescence intensity of the internalised particles 
(having corrected for any background fluorescence) and as such provides a quantifiable and 
unbiased measure of particle accumulation within the cell.  
Statistical analyses 
Data were analyzed by one-way ANOVA, with Bonferroni’s post-hoc multiple comparison test (Prism 
software, version 6.03; GraphPad, CA, USA). All data are expressed as mean ± standard error of 
the mean (SEM) with ‘n’ referring to the number of different cultures, each derived from a different 
rat litter. 
 
Results  
Astrocyte uptake characteristics for particles with differing proportions of magnetite: 
Astrocyte cultures used in our study were of high purity as judged by expression of the astrocyte 
marker GFAP (99.4 ± 0.2% of cells were GFAP+, n = 6). Cells displayed healthy morphologies typical 
of Type 1 and Type 2 astrocytes (Fig. 1, a), with Type 1 cells dominating (92.4 ± 1.0% of GFAP+ 
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cells). Both perinuclear and cytoplasmic distributions of MPs were observed post-labeling (Fig. 1, a-
c). Visual analysis showed widespread cellular uptake throughout cultures for all three particle types, 
and revealed cellular heterogeneity in terms of relative particle accumulation showing low, medium 
or high uptake (Fig. 1, a-c). 
Particle uptake was rapid, and for magnetite-loaded cells a substantial proportion (ca. 50%) of cells 
were MP-labeled at 4 h post-particle exposure; MP-5x particles showed significantly increased 
labeling efficiency versus the other particle types, and in turn, MP-1x showed significantly increased 
MP-labeling versus MP-0x (Fig. 1, d). By contrast, magnetic field application had no effect on 
labeling efficiency with MP-0x or MP-1x particles at 4 h. Further, magnetic fields had no effect on 
the proportion of cells labeled with the MP-5x particles, which was very high (>90%) even under the 
no magnetic field condition. With regard to the extent of particle accumulation at 4 h, cells labeled 
with MP-5x particles showed significantly higher particle accumulation compared with MP-0x and 
MP-1x particles for both magnetic field conditions (Fig. 1,e); fields also resulted in significantly 
greater accumulation of MP-5x particles versus the no field condition (Fig. 1, e). 
At 24 h, a greater proportion of cells were MP-labeled versus 4 h for all particle types (compare Fig. 
1, d and f). Notably, for MP-1x and MP-5x particles, virtually all (>98%) astrocytes were MP-labeled 
(Fig. 1, f); magnetic field application at both frequencies was without effect at this time point. The 
extent of particle accumulation was also much greater at 24 h compared to 4 h for all magnetite 
containing particles (compare Fig. 1, e and g; please note scale difference of y-axes), with particle 
accumulation significantly higher versus MP-0x (Fig. 1, g). Further, for MP-5x particles magnetic 
field application promoted particle accumulation (Fig. 1, g) but the effect was not observed for MP-
1x.  
Long term particle retention analysis: Long term particle retention was studied for magnetite 
containing particles with applied oscillating fields, which yield optimal MP loading using our 
protocols. For both MP-1x and MP-5x, substantial label retention (>50%) was evident over 21 days. 
For MP-1x particles, approximately 92% of cells were labeled at day 1 and this value declined 
11 
 
significantly by day 17 to ca. 51% of cells (Fig. 2; a). For MP-5x particles, in contrast, a greater 
labeling efficiency (ca. 99% of cells) was obtained at day 1, which declined significantly by day 21, 
albeit with >78% of cells remaining labeled at this time point (Fig. 2, b). A steady reduction in particle 
retention was noted over the 21 day time period, with considerable heterogeneity observed over 
cells in terms of extent of particle retention. Visual observations over time for MP-1x showed a clear 
transition from perinuclear clustering of particles (Fig. 2, c, inset) to a more cytoplasmic distribution 
(Fig. 2, c, main image) suggesting reverse trafficking of particles. Whilst a similar pattern was seen 
overall with MP-5x (Fig 2, d, inset), it was noticeable that a sub-population of astrocytes retained 
large particle accumulations clustered around the nucleus even at 21 days (Fig 2, d, main image). 
Extent of particle retention was lower for MP-1x than MP-5x particles (compare Fig. 2, e and f: 
please note scale difference of y-axes).  
Safety assessment of long term particle retention: Long term retention of the particles did not 
impair the proliferative capacity of astrocytes, with average cell numbers showing a significant 
increase by day 9 for both MP-1x and MP-5x particles and for both magnetic field conditions, with 
no significant differences compared to untreated controls at 21 days (Fig. 3, a- b). Culture purity 
remained at >99% over the 21 days (Fig. 3, c-d). There was no effect of either particles or magnetic 
field condition on astrocyte phenotype distribution (84.6 ± 0.7% Type 1 compared with 15.4 ± 0.7% 
Type 2, average across all conditions; Fig. 3, e-f). A small proportion (<2%) of nuclei were pyknotic 
across all time points; pyknosis was associated with aberrant intense GFAP staining indicative of 
membrane detaching from the substrate (Fig. 4, a-b). By contrast, using histological analyses, the 
majority of labeled cells showed no obvious aberrations in GFAP staining or in astrocyte 
morphologies compared with controls.  
Live cell imaging of particle inheritance in dividing astrocytes: To gain further insight into the 
pattern of particle distribution into daughter cells, astrocytes labelled with MP-5x particles were 
studied using dynamic time-lapse imaging of proliferating cells (Fig. 5; See Supplementary data for 
associated video file). This revealed that daughter cells exhibited a predominantly asymmetric profile 
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of particle inheritance (from 30 mitotic events, 21 were asymmetric compared with 9 showing 
symmetrical inheritance; Fig. 5, a). Distribution of particles within the parent cell prior to division (Fig. 
5, b & f) was predictive of the inheritance profile in daughter cells. Parent cells exhibiting a symmetric 
perinuclear distribution of particles (Fig. 5, b-d) gave rise to daughter cells with symmetric 
inheritance of particles (Fig. 5, e), and mitosis of parent cells with asymmetrically-distributed 
particles resulted in asymmetric inheritance (Fig. 5, i). 
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Discussion 
Here, we have investigated the interaction between the physicochemical properties (specifically, 
magnetite content) of polymeric iron oxide particles and a highly endocytotic neural cell (the 
astrocyte). When trying to achieve intracellular particle uptake by transplant populations, two 
delivery routes can be considered. Either intrinsic ‘engulfing’ behaviours of cells can be exploited, 
or the membrane can be temporarily disrupted (e.g. by electroporation or ultrasound bubble 
stimulation [32]). As the former approach relies on natural biological mechanisms, it can be argued 
that this offers a safer and more attractive labeling approach, particularly when long term safety (for 
example post-transplantation into host tissue) is a critical consideration [33,34]. Generally speaking 
however, the relative endocytotic behaviours of major neural transplant populations have been 
poorly documented. In turn, the combinatorial interactions of such engulfing mechanisms with the 
physicochemical properties of particles have received little attention, but remain an important issue 
when developing neural transplant labeling methods. It can be predicted that the effectiveness of 
different labeling approaches may vary depending on the cell type and particle deployed, and 
protocols will need to be tailored for individual cell/particle combinations. 
As far as we are aware, the integrated density-based approach that we have utilized has never been 
applied for quantification of nanoparticle uptake in cells, providing an unbiased, objective approach 
at the single-cell level whilst allowing for simultaneous evaluation of cellular morphological features 
and subcellular particle localization. We demonstrate that enhanced magnetite concentration in 
particles leads to greater particle loading in highly endocytotically active cells. This is associated 
with longer particle retention (≥ 21 days) versus cells loaded with particles of lower/no magnetite 
content. Greater labeling efficiency with high magnetite particles within a short time frame is likely 
attributable to accelerated gravitational particle sedimentation onto cells (due to the increased 
particle density), similar to the mechanism by which applied magnetic fields enhance transfection-
grade MP-mediated gene transfer to target cells (‘magnetofection’). This technique is now an 
established experimental procedure, used widely in laboratories in genetic modification protocols 
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[35], but the compatibility of this approach with a wider range of MPs (e.g. clinical contrast agents 
or polymeric particles for drug delivery/magnetic cell targeting) is still relatively unexplored. With the 
magnetic particles studied here, application of static or oscillating fields did not influence the 
proportions of cells labeled, but significantly enhanced the extent of intracellular particle 
accumulation. Together, our data suggest that a tailored combination of magnetic field application, 
high magnetite content particles, and longer particle exposure times operate synergistically allowing 
for greater labeling efficiencies to be achieved. The prolonged retention of higher magnetite content 
particles is of high relevance for translational applications, where proliferative dilution/exocytosis 
and label loss are known to be major challenges [5,36].  It is possible that the longer retention is 
simply related to higher initial loading into cells, but we cannot rule out effects such as slower 
exocytosis of higher magnetite content particles. The combination of high survival of our transplant 
populations post-labeling in conjunction with such slower excretion, may serve to reduce the 
instance of ‘false positive’ signals, due to secondary uptake by cell populations such as the resident 
astrocytes and microglial cells in host tissue. 
The overall trend in labeling was similar to that seen in NSCs, although magnetic field application 
did significantly enhance labeling efficiency with low magnetite content particles in the latter [8]. We 
can speculate that the higher levels of endocytotic activity in astrocytes result in rapid particle uptake 
and outweigh the benefits of field application, particularly for higher magnetite content particles with 
more rapid sedimentary profiles. Further, microscopic observations reveal that for a given condition, 
the intracellular label per cell is greater in astrocytes versus NSCs. The reasons for this may be 
related to the morphological features and relative endocytotic profiles of the cells. For example, 
scanning electron micrographs show broad, flattened morphologies for astrocytes with elaboration 
of large amounts of cell membrane, and surface features suggestive of high cellular membrane 
activity (Fig. 6a). By contrast, NSCs are bipolar cells with smaller cell bodies, relatively quiescent 
membranes and less surface area available for particle uptake (Fig. 6 b); additionally label loss 
appeared to occur rapidly from NSCs (within one week, unpublished observations). Taken together, 
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our findings highlight the importance of studying the interactions of neural cell type and endocytotic 
behaviours in conjunction with particle tailoring strategies.  
They also indicate the potential benefits of ‘endocytosis pre-stimulation’ strategies in enhancing 
particle uptake, although such strategies are not routinely used currently in labeling protocols. These 
could include serum starvation [37], growth factor stimulation [38] or mechanical stimulation (as 
deforming or shear forces may stimulate endocytosis [28]). A less obvious point to note here is the 
importance of controlling cell densities for such work; in some populations containing actively 
dividing cells, there is a density dependent inhibition of endocytosis which could negatively impact 
particle uptake processes [39]. The majority of neural transplant populations are highly proliferative 
and are usually propagated under growth factor drive, so the optimal cell densities for each cell type 
must be established and cellular confluence carefully monitored prior to particle addition in labeling 
protocols for biomedical applications. 
The safety of the procedures utilized here was of paramount concern, given the combined variation 
of multiple parameters (particle properties, magnetic field application and duration of particle 
exposure). The procedures did not result in acute or long term alterations in magnetolabeled cells, 
as determined by a spectrum of safety assays assessing survival, proliferative capacity, and cell 
phenotype. This finding parallels our previous observations in NSCs, highlighting the 
neurocompatibility of the particles used [8]. The safety profile of these MPs could be attributable to 
the slow degradation profile of the PLA matrix component (limiting the rate at which iron leaches 
from degrading particles; rapid leaching is a major correlate of MP toxicity [40,41]), and is also 
consistent with the observed stability of intracellular MPs in astrocytes [7]. We have used histological 
analyses to evaluate particle safety, however astrocytes participate in complex signalling pathways 
and secrete several biomolecules needed for homeostatic function [16,18,19]. More detailed 
readouts of safety will require combined proteomic and bioinformatic pathway analyses of potential 
dysregulated processes in magnetolabeled astrocytes, to establish if particular secretory 
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mechanisms or individual proteins involved in regenerative processes or signalling pathways are 
perturbed by the labeling procedures.  
As far as we are aware, our study is the first to use a dynamic, live cell imaging approach to study 
the distribution (inheritance) of MPs into the progeny of neural cells derived from primary cultures. 
Our observations that particle inheritance is largely asymmetric (in that particle distributions are 
uneven between daughter cells, post-proliferation), are consistent with previous observations in cell 
lines wherein particle uptake and redistribution to daughter cells after mitosis, is a “random” and 
asymmetric process [5,36,42,43]. The reasons for this uneven inheritance are unclear, but may 
relate to non-uniform distribution of MPs around the nuclear poles, which we consistently observed 
in the majority (ca. 75%) of labeled astrocytes. In turn, the reasons for this polarized initial distribution 
are unknown. Nonetheless, we consider that our findings do have significant implications for the use 
of the MP platform for biomedical applications involving astrocytes, and indeed other proliferative 
neural transplant populations. Label loss with cell division contributes to reduced efficacy of particle 
labeling for imaging/targeting applications; however our results indicate that not all transplant cells 
would be affected similarly in this regard. Unequal inheritance would imply that with each division, 
the utility of the intracellular MP label would exponentially diminish for a subpopulation of daughter 
cells. On the other hand, useful levels of labeling would persist in a larger subpopulation for a longer 
period of time (than would be predicted with symmetric inheritance) resulting in the ability to track 
overall biodistribution of the cellular graft, even if some cells are lost to the imaging process. 
Consequently, we believe that an understanding/characterization of the specific modes of particle 
inheritance in the progeny of a given labeled transplant population, is an important parameter 
contributing to particle detection, and must be taken into consideration in studies aiming to optimize 
MP labeling for neural cell therapies. In summary, a wide range of biological and chemical 
parameters exert an influence on the utility of the MP platform for neural transplantation therapies 
(Fig. 7) but require systematic investigation. A detailed understanding of the relative importance of 
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each of these parameters will allow for the tailored development of optimal labeling protocols for 
translational applications. 
Conclusion 
We show that initial greater MP cell loading achieved using high magnetite content polymeric 
particles in highly endocytotic neural cells, leads to enhanced cellular particle retention. The 
inheritance of particles into daughter cells, studied using dynamic live cell imaging, is predominantly 
asymmetric/unequal which we consider will have significant implications for tracking of labeled cells 
in imaging applications. 
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Executive summary 
Effective tracking of neural transplant populations using magnetic particles requires efficient 
cell labeling 
• This involves high initial cellular loading and effective particle retention for clinically 
relevant periods in labeled populations. 
• The synergistic interactions of biological properties such as cellular endocytotic 
capacity and physicochemical properties such as particle magnetite content in neural 
cells are not known. 
Tailored nanoparticle and protocol design can increase the efficacy of transplant cell-
labeling 
• Rapid and efficient particle uptake is achieved using particles with high magnetite 
content versus those with low/no magnetite. 
• Higher magnetite particles are also associated with longer term particle retention in 
cells. 
• Applied magnetic fields/gradients did not affect cell labeling efficiency, but did 
increase extent of cell loading for higher magnetite particles. 
Most neural transplant populations are proliferative, and cell division dilutes particle label 
limiting tracking capacity 
• Few studies have investigated the pattern of particle ‘inheritance’ into daughter cells 
post-division. 
• Mitosis typically results in asymmetric particle distribution: daughter cells do not 
inherit equal proportions of particles.  
• The implications for such unequal particle distribution remain to be established with 
complementary MRI studies. 
Conclusions 
• Our data can provide valuable information to transplantation biologists and materials 
chemists to develop effective protocols for labeling cell transplant populations. 
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Supporting information available: Video 1. Time lapse micrographs of astrocyte culture 8 h post-
addition of MP-5x particles. Arrows indicate two mitotic events, with examples of both asymmetric 
(red arrow, upper half, occurring at time-point ~01:50; 70:30 inheritance split) and symmetric (white 
arrow, lower half, occurring at time-point ~01:32; 50:50 inheritance split) MP inheritance. 
 
Abbreviations: CNS – central nervous system; DAPI – 4’,6-diamidino-2-phenylindole; GFAP – glial 
fibrillary acidic protein; MP – magnetic particle; NdFeB – neodymium iron boron; NSC – neural stem 
cell; PBS – phosphate buffered saline; PDL – poly-D-lysine; PLA – poly(lactic acid); PVA – poly(vinyl 
alcohol). 
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Table 1. Physical characterization of magnetic particles. 
Magnetic particle Magnetite content (w/w) Hydrodynamic diameter 
(nm) 
ζ-potential (mV) 
MP-0x Non-magnetite 267 ± 0.65 -8.98 ± 0.16 
MP-1x 11.5 ± 0.98 262 ± 9.56 -9.46 ± 0.14 
MP-5x 46.0 ± 1.08        278 ± 1.62    -14.4 ± 0.34 
Data from [8, 26]. 
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Figure 1. MP-labeling of astrocytes at 4 h and 24 h post-particle exposure, with and without magnetic field application. 
(a-c) Representative triple-merged images of MP-5x particle uptake in Type 1 and Type 2 (a-inset) astrocytes (24 h). 
Arrows indicate (a) ‘low’, (b) ‘medium’ and (c) ‘high’ levels of intracellular particle accumulation. (b, inset) z-stack 
micrograph demonstrating intracellular localization of particles. (d) Bar chart displaying MP-labeling efficiency in 
astrocytes at 4 h. (e) Bar chart showing extent of particle accumulation across magnetic fields at 4 h. (f) Bar chart 
showing MP-labeling efficiency at 24 h. (g) Bar chart showing extent of particle accumulation across magnetic fields at 
24 h. Differences are indicated in terms of magnetic field (†††P < 0.001) and particle (*P < 0.05, **P < 0.01, ***P < 0.001). 
All graphs: n = 6. 
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Figure 2. Long term particle retention following 30 min application of an oscillating magnetic field. Bar charts showing 
proportions of labeled cells post-exposure to (a) MP-1x and (b) MP-5x particles (***P < 0.001). (c) & (d) Representative 
triple-merged images showing differences in levels of particle accumulation seen at day 1 (insets) and day 21 (main 
images) post-labeling with (c) MP-1x and (d) MP-5x particles. Arrows indicate ‘high’ levels of perinuclear labeling at day 
21 with MP-5x particles. Bar charts displaying levels of (e) MP-1x and (f) MP-5x particle accumulation over 21 days 
following exposure to oscillating magnetic field. Within each particle condition, versus day 1:(*P < 0.05, **P < 0.01, ***P 
< 0.001). All graphs: n = 3. 
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Figure 3. Safety assessment of long term particle retention. Bar charts displaying astrocyte number per microscopic 
field post-labeling under (a) static and (b) oscillating magnetic field conditions (*P < 0.05 & ***P < 0.001 versus day 1). 
Bar charts displaying proportions of GFAP+ cells post-labeling under (c) static field and (d) oscillating field conditions. 
Bar charts showing the distribution of astrocyte phenotypes post-labeling under (e) static field and (f) oscillating field 
conditions. All graphs: n = 3. 
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Figure 4. Identification of pyknotic cells in astrocyte cultures. (a) The viability of astrocyte cultures was assessed by 
identifying cells with fragmenting and condensing nuclei, frequently associated with aberrant GFAP staining and 
evidence of membrane detachment from the substrate, all features indicative of pyknosis (red arrows indicate same 
pyknotic cell in main image and inset). Healthy nuclei were associated with adherent cells and normal GFAP staining 
(white arrows indicate same cells in main image and inset). (b) The percentage of pyknotic nuclei did not vary across 
conditions or time-points (P > 0.05). All graphs: n=3. 
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Figure 5. Particle inheritance in labeled astrocytes. (a) Pie chart displaying quantification of particle inheritance profiles 
in MP-labeled astrocytes. (b) – (i) Representative sequential still images from dynamic time-lapse imaging 
(Supplementary data) of dividing astrocytes post- labeling with MP-5x particles without a magnetic field, showing 
examples of (b-e) symmetric and (f-i) asymmetric particle inheritance between daughter cells (arrows). 
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Figure 6. Scanning electron micrographs of (a) an astrocyte, and (b) a neural stem cell (NSC), for comparison of typical 
morphological characteristics. Note the differences between the two cell types in terms of both quantity of membrane 
available for particle interactions, and the quantity of specific membraneous features associated with endocytotic 
activity, such as processes, filopodia and ruffles. Electron microscopy and NSC culture methods published previously 
[21]. 
 
 
 
 
Figure 7. Schematic diagram showing factors that influence cell loading with particles, illustrating the combined 
dynamics of (i) the physicochemical characteristics of magnetic particles (MPs), and (ii) the biological function of the 
cell. Micrograph shows MP-5x labeled astrocytes.  
 
 
